We investigated whether the type of left ventricular (LV) geometry is associated with left atrial (LA) size as determined either by LA diameter or by volume, indexed for body surface area, in essential hypertensives. A total of 339 consecutive, untreated, hypertensives (aged 51.8 years, 234 males) underwent 24-h ambulatory blood pressure (BP) monitoring and estimation of LA diameter and volume, as well as LV structure and function by echocardiography. LV hypertrophy was present in 130 (38.3%) patients whereas normal geometry (LV-NG), concentric remodeling (LV-CR), concentric hypertrophy (LV-CH) and eccentric hypertrophy (LV-EH) represented 34.5, 27.1, 25.7 and 12.7%, respectively. Patients with either LV-CH or LV-EH had increased LA diameter index compared with those with either LV-NG (by 1.1 mm m -2 , Po0.01 and 1.4 mm m -2 , P ¼ 0.003, respectively) or LV-CR (by 1.3 mm m -2 , P ¼ 0.003 and 1.6 mm m -2 , P ¼ 0.001, respectively). Similarly, patients with either LV-CH or LV-EH had significantly increased LA volume index compared with those with either LV-NG (by 3.2 ml m -2 , Po0.001 and 3.4 ml m -2 , Po0.005, respectively) or LV-CR (by 4.5 and 4.7 ml m -2 , respectively, Po0.001 for both). Multiple linear regression analysis showed that the independent predictors of both LA volume and diameter index were LV mass index, 24-h pulse pressure and E/Em.LA size assessed either by its diameter or by volume is closely related only to LV mass index and not to any specific LV geometric pattern in the early stages of essential hypertension.
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Introduction
Left atrial (LA) enlargement represents an early and common finding in hypertensive heart disease 1, 2 and, along with increased left ventricular (LV) mass, has been identified as an independent determinant of new-onset atrial fibrillation and ischemic stroke. [3] [4] [5] Nowadays, the focus on upstream therapies for atrial fibrillation targeting on its substrate makes the assessment of LA alterations an interesting issue.
According to the recent European Society of Hypertension guidelines, not only LV hypertrophy but also its geometric pattern contributes to the risk stratification of hypertensive patients. 6 However, controversial data still exist, as to whether the type of LV geometry affects LA size in hypertensive patients. Thus, in a LIFE (Losartan Intervention for Endpoint Reduction in Hypertension) substudy, increased LA diameter was significantly related to the presence of eccentric LV hypertrophy 7 whereas in another study, larger LA volume was associated with concentric LV hypertrophy. 8 In contrast, Cuspidi et al. 9 in a large population of hypertensives, showed that LA diameter was not related to the type of LV hypertrophy.
Therefore, the aim of this study was to investigate whether the type of LV geometry is associated with LA size as determined either by LA diameter or by LA volume adjusted for body surface area, in untreated essential hypertensive patients.
Methods

Study population
We studied 405 consecutive untreated non-diabetic patients, with newly diagnosed (within the earlier 2 years) stage I-II essential hypertension, who were referred to the outpatient hypertension unit of our institution during a period of 2 years. The presence and severity of hypertension were determined on the basis of office blood pressure (BP) measurements, according to the European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension (BP 4140/90 mm Hg) 6 and confirmed by 24-h ambulatory systolic BP 4130 or 24-h ambulatory diastolic BP 480 mm Hg. All patients underwent the usual clinical and laboratory work-up to rule out secondary hypertension.
Patients with a history of clinically apparent coronary heart disease, congestive heart failure, valvular heart disease, chronic obstructive pulmonary disease, permanent pacemaker or atrial fibrillation were excluded from the study, as well as patients with morbid obesity (body mass index 440 kg m -2 ) or any other significant systemic disease. Finally, 339 patients, fulfilling the above criteria, were selected for participation in this study.
All participants underwent anthropometric measurements, evaluation of metabolic profile, 24-h ambulatory BP monitoring and a complete echocardiographic examination. The study protocol was approved by the ethics committee of our institution, was concordant with the Code of Ethics of the World Medical Association and all participants gave written informed consent.
Procedures 24-h ambulatory BP monitoring. Ambulatory BP was recorded over a working day (Monday to Friday) using the automatic SpaceLabs Unit 90217 (Redmond, WA, USA). The procedure has been described earlier in detail. 10 In brief, the cuff was fixed to the non-dominant arm and the device was set to obtain automatic BP and heart rate readings at 15-min intervals during daytime and at 30-min intervals during nighttime. Short clock-fixed time intervals were used for the delineation of daytime and nighttime, defined as lasting from 10 am to 8 pm and from midnight to 6 am, respectively. The data were considered adequate, when a minimum of 70% valid recordings were obtained during the 24-h measurement period.
Cardiac ultrasonography. The echocardiographic studies were conducted by an experienced senior cardiosonographer using a Vivid 3 PRO (General Electric, Milwaukee, WI, USA) ultrasound imager equipped with a 2.5-5 MHz (harmonics) phasedarray 3S transducer, under continuous electrocardiographic recording, according to the guidelines of the American Society of Echocardiography. 11, 12 As described earlier, the data were initially saved on the machine's archive (digital archive, raw data), and measurements were subsequently carried out by two independent operators, blinded to the patients' demographics and BP status. 13 The standard 2D and M-mode measurements, such as interventricular septum thickness, LV posterior wall thickness and LV end-systolic and end-diastolic diameter were averaged from five consecutive cardiac cycles. The LV mass was calculated using the regression equation recommended by the American Society of Echocardiography 14 and was indexed for body surface area to estimate the LV mass index. Subsequently, relative wall thickness was calculated as the ratio (interventricular septum thickness þ LV posterior wall thickness)/LV end-diastolic diameter. 15 A normal LV mass index was defined as that lower than 116 and 104 g m -2 in males and females, respectively. 16 A partition value for relative wall thickness of o0.43 was used for both normal males and females. 17 According to the above LV mass index and relative wall thickness values, patients with increased LV mass index and increased relative wall thickness were considered to have LV-CH, and those with increased LV mass index and normal relative wall thickness were considered to have eccentric hypertrophy (LV-EH). Those with normal LV mass index and increased or normal relative wall thickness were considered to have LV-CR or LV-NG, respectively. 18 Regarding LA dimensions, the LA diameter was measured by 2D-guided M-mode echocardiography obtained in the parasternal short-axis view at the base of the heart, and was indexed for body surface area, so as to provide the LA diameter index. 19 Three LA diameters were used to calculate LA volume as an ellipse, using the formula LA volume ¼ p/6 (SA 1 Â SA 2 Â LX), where SA 1 ¼ the M-mode LA diameter from the short-axis view and SA 2 and LX are measurements of short and long axis in the apical four-chamber view at ventricular end-systole. 20 The LA volume was indexed for body surface area to estimate the LA volume index as we have described earlier. 21 Left ventricular diastolic function was determined using both conventional Doppler parameters (E/A waves ratio of the transmitral flow, isovolumic relaxation time, deceleration time of the E wave and the peak velocities of E and A waves) and tissue Doppler imaging (TDI)-derived indices (peak early diastolic velocity (Em) and peak atrial systolic velocity (Am)), averaging the mean values obtained from measurements at the basal site of lateral, septal, anterior and inferior walls in five consecutive cardiac cycles, as described earlier. 22 Statistical analysis SPSS statistical package, release 12.0 (SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. All descriptive continuous variables are presented as means and standard deviations because of their normal distribution. Significant differences between the study subgroups were determined using analysis of variance (ANOVA) and Tukey post hoc analysis or the chi-square test, where appropriate. Simple bivariate correlation analysis was carried out using Pearson's r correlation coefficient.
Stepwise linear regression analysis was used to examine the significant predictors of the LA volume index and LA diameter in separate models. Preliminary checks were conducted, to ensure that there was no violation of the assumptions of each test used. All tests were considered to be significant at the level of Po0.05.
Results
Our final study population consisted of 339 patients (aged 51.8 ± 10 years, 234 males). According to used gender-specific criteria, LV hypertrophy was present in 130 (38.3%)patients. Regarding LV geometry, 117 (34.5%) patients had LV-NG, 92 (27.1%) had LV-CR, whereas LV-CH was recognized in 87 patients (25.7%) and LV-EH in 43 (12.7%).
The demographic and clinical characteristics of the four groups of LV geometry are shown in Table 1 . All patients were of similar age, apart from those with LV-EH who were older by 4 years compared with those with LV-NG and by 3.5 years compared with those with LV-CR (Po0.05 for both). Also, the four groups did not differ regarding gender and body mass index (P ¼ NS for all cases). Patients with LV-CH had significantly increased 24-h systolic BP compared with those with LV-NG (by 7 mm Hg, Po0.001), those with LV-CR (by 6 mm Hg, Po0.005) and those with LV-EH (by 6 mm Hg, Po0.05), as well as increased 24-h pulse pressure compared with those with LV-NG (by 3 mm Hg, Po0.01) and those with LV-CR (by 5 mm Hg, Po0.001).
Regarding echocardiographic parameters, patients with patterns with increased LV mass (LV-CH and LV-EH) had impaired LV diastolic function compared with those with LV-NG and LV-CR (Table 2) , whereas no significant differences were observed between the LV-CH and LV-EH subgroups.
The LA diameter index did not differ between patients with LV-NG and those with LV-CR nor between patients with LV-CH and those with LV-EH (P ¼ NS for both cases). In contrast, patients with either LV-CH or LV-EH had significantly increased LA diameter compared with those with either LV-NG (by 1.1 mm m -2 , P ¼ 0.01 and 1.4 mm m -2 , P ¼ 0.003, respectively) or LV-CR (by 1.3 mm m -2 , P ¼ 0.003 and 1.6 mm m -2 , P ¼ 0.001, respectively) ( Table 2 ) (Figure 1, upper panel) .
Similarly, the LA volume index did not differ between patients with LV-NG and those with LV-CR or between patients with LV-CR and those with LV-EH (P ¼ NS for all cases). However, patients with LV-CH and LV-EH had significantly increased LA volume index compared with those with LV-NG (by 3.2 ml m -2 , Po0.001 and 3.4 ml m -2 , Po0.005, respectively) and those with LV-CR (by 4.5 and 4.7 ml m -2 , respectively, Po0.001 for both) (Figure 1,  lower panel) .
In the overall population of hypertensive patients, the LA volume index showed positive correlations with age (r ¼ 0.168, Po0.005), office systolic BP (r ¼ 0. Stepwise linear regression analysis showed that the independent predictors of LA volume index were LV mass index (b ¼ 0.283, Po0.0005), 24-h pulse pressure (b ¼ 0.165, P ¼ 0.002) and E/Em (b ¼ 0.134, P ¼ 0.010). The candidate's explanatory independent variables entering in the multiple regression model were also age, gender, body mass index, smoking status and relative wall thickness, and the R for the regression model was 0.402 (Po0.0005). Similarly, by applying a second multiple regression model with the same independent variables (R ¼ 0.377, Po0.0005), it was shown that the independent predictors of the LA diameter index were also LV mass index (b ¼ 0.196, Po0.0005), 
Discussion
The main finding of our study was that specific geometric pattern of LV hypertrophy has no effect on LA size regardless of the way it is expressed (diameter or volume) in the early stages of essential hypertension. Moreover, LV mass index emerges as a major determinant of LA enlargement independently of confounders.
Compelling evidence shows that hypertensioninduced LA structural and functional alterations are associated with the presence of atrial fibrillation, 5 ischemic stroke [3] [4] [5] and congestive heart failure. 23 Thus, the recent (European Society of Cardiology) ESC/(European Society of Hypertension) ESH guidelines underscore the additive value of LA size determination for the risk stratification of hypertensives. In these lines, the LA volume compared with diameter seems to represent a more accurate estimate of the LA size but with attenuated clinical applicability. 24 This is the first study in which the association of LA size with LV geometry was assessed by measuring both LA diameter and volume in the setting of hypertensive patients. Given the confounding effect of body habitus on LA adaptations, we further indexed for body surface area. We found that these two expressions of LA size are not only interrelated but are also determined by the same predictors among which LVMI plays a dominant role. In other words, patients with LV-CH and LV-EH who represent the subgroups with increased LV mass were accompanied by increased LA diameter and LA volume compared with those with LV-NG and LV-CR.
Focusing on the association between LA size and specific LV geometry patterns, the data are rather scarce. The authors showed that LV geometry does not participate in the process of LA remodelling assessed by both diameter and volume index. These results are in line with earlier reports of Cuspidi et al. 9 in which LA diameter was unrelated to the type of LV hypertrophy. In contrast, in the LIFE substudy including hypertensive patients with electrocardiographic LV hypertrophy, the LA diameter was significantly related to the presence of LV-EH, 7 whereas in another hypertensive population the LV-CH was associated with greater LA size than LV-EH. 8 These discrepancies with our results might be attributed to the differences in duration and severity of hypertension, in treatment status and to the lack of adjustment for body size.
Left ventricular mass, ambulatory pulse pressure and E/Em ratio proved also to be significant determinants of LA size (diameter or volume) in our population. These associations add a mechanistic link in the pathophysiological chain between arterial stiffening, LV diastolic properties and LA in hypertensive patients. More specifically, the Left atrial adaptations in hypertension C Tsioufis et al catalytic effect of LV mass on LA enlargement is pathophysiologically established and contributes, at least partially, to the augmented risk that characterizes hypertension with LV hypertrophy. [25] [26] [27] Extending the above ambulatory pulse pressure reflects increased aortic stiffness that triggers processes involved in LV mass increase, compromise of coronary reserve and worsening of LV diastolic properties leading to structural and functional alterations of LA. The association of the E/Em ratio, which reflects LV end diastolic pressure with LA size, supports the earlier concept and is in accordance with past reports. 28, 29 From a clinical point of view, our findings suggest that LA diameter and volume can be used interchangeably for the evaluation of the relationship of LA size with LV geometry. Moreover, the authors confirmed the unequivocal role of LV hypertrophy in LA enlargement, strengthening the need for more aggressive and appropriate antihypertensive treatment, focusing on the substrate of both chambers. The rather selected population of untreated newly diagnosed hypertensives and the relatively strict gender-specific criteria for the definition of LV hypertrophy, limit our ability to apply these results to all hypertensives. The limited size of the cohort and the cross-sectional nature of our study limit the possibility of linking LA and LV relationships with cardiovascular outcomes and further restrict the generalizability of our results.
In conclusion, LA size assessed either by its diameter or by volume is closely related only to LV mass index and not to any specific LV geometric pattern in the early stages of essential hypertension. The close association between pulsatile load, LV mass, diastolic properties and LA size further explains the pathophysiological link between the structural and functional properties of these two chambers in essential hypertension. What is known about this topic K Atrial enlargement represents an independent predictor of cardiovascular risk involving predominantly atrial fibrillation, ischemic stroke and congestive heart failure K Left ventricular hypertrophy has been associated with increased risk for cardiovascular morbidity and mortality. 
